logo
episode-header-image
Mar 2023
47m 39s

Prof G Markets: Scott’s NJOY Stake, the ...

VOX MEDIA PODCAST NETWORK
About this episode

This week on Prof G Markets, Scott gives the inside scoop on his early investment in NJOY, which will reap 30x in returns after Altria's acquisition of the vape company goes through. He also shares his thoughts on whether or not the JetBlue/Spirit Merger should be blocked, and takes a look at WeightWatchers’ move into the weight loss drug market. For more on Silicon Valley Bank’s collapse, check out our special episode from Saturday and stay tuned.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Up next
Aug 25
The Future of Prof G Media, How We Make the Podcast, and Why Scott Became a Professor
Scott kicks off a special “Best Of” Office Hours series focused on his favorite topic: himself. He takes questions on what happens to Prof G Media after him, how he built a portfolio of top podcasts, and what motivated him to step into the classroom at NYU. Scott also shares his ... Show More
24m 41s
Aug 23
No Mercy / No Malice: Good Ideas Will Save the Country
Written by Jessica Tarlov. As read by George Hahn. https://www.profgalloway.com/good-ideas-will-save-the-country/ Learn more about your ad choices. Visit podcastchoices.com/adchoices 
17m 35s
Aug 22
Raising Modern Men: A Mother’s Perspective (A Lost Boys Special)
We’re wrapping up the Lost Boys series in the Prof G feed with this final episode. Anthony Scaramucci and Scott Galloway sit down with a very special guest to explore a mother’s perspective on raising modern men – from the challenges young men face today to how parents can help t ... Show More
1h 2m
Recommended Episodes
Jun 2024
The Texas Stock Exchange + Is Short Selling a Dying Strategy?
Scott shares his thoughts on why the new Texas Stock Exchange could be an appealing choice for certain companies. He also explains how it's a symptom of a larger issue: the politicization of everything. Then Scott and Ed break down the role that short sellers have historically pl ... Show More
46m 8s
Feb 2021
Retail, Tech Earnings, and Berkshire’s Surprising Buys
Walmart shares slip on earnings. The Trade Desk surges on record revenue. Roku rises on an unexpected profit. Fastly falls on growth concerns. Shopify slips. CVS Health treads water. Berkshire-Hathaway makes some big investments. And Marriott suffers a big loss with the death of ... Show More
39m 10s
Sep 2020
Investor's Guide To The Election (Linette Lopez and Bill Sweet), Snowflake Hot Take, Shorting Nikola (Michael Batnick)
This week Josh talks to Business Insider columnist Linette Lopez about what happens to the stock market if Trump loses and doesn't leave. And is Joe Biden so terrible for investors? Tax expert and Ritholtz Wealth CFO Bill Sweet weighs in. Plus, Josh's take on the explosive Snowfl ... Show More
1h 35m
Dec 2019
Next Week’s Game Plan, BootBarn CEO, Grocery Outlet CEO, & Natera CEO
The Dow finished the week soaring 337 points higher and Jim Cramer’s breaking down today’s market moves and giving you his Game Plan for next week’s action. Then, Mad Money saddles up for Jim Conroy, CEO of BootBarn, to visit the studio to discuss the company’s impressive third q ... Show More
44m 4s
Apr 2024
Fed Decision Kick-Off, Amazon and Apple Results, and Busiest Week of Earnings Season 4/29/24
Investors are awaiting the kickoff to this week's Fed decision. The Milken Institute's Bill Lee gives his expectations. Plus, Amazon and Apple are set to deliver results in what could be two market-moving events. Janus Henderson's Alison Porter explains. And, it's busiest week of ... Show More
42m 36s
Jun 2021
Software Eating The World, Healthcare Stocks to Watch
Adobe hits an all-time high on earnings. Kroger raises guidance and announces a $1B stock buyback. The Honest Company issues its first report as a public company. Homebuilder Lennar posts strong profits. And electric-truck maker Lordstown Motors needs new management. Ron Gross an ... Show More
39m 10s
Nov 2022
Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos
The big three healthcare companies aren’t paying much attention to Mark Cuban’s new health care venture, Cost Plus Drugs. But their margins could mean a huge opportunity for the new start-up. Chris Hill caught up with Cuban to discuss: - Why he’s able to sell a leukemia drug for ... Show More
19m 20s
Jun 2024
Biden/Trump Debate Moves Prediction Markets & Amazon’s Plan to Take Down Temu and Shein
Episode 354: Neal and Toby recap the 1st presidential debate between President Biden and Republican nominee Donald Trump. Then, the Supreme Court rejects the Purdue Pharma settlement that would’ve sent billions to treatment programs affected by the opioid crisis but shielded the ... Show More
28m 21s
Jul 2023
Ro CEO Zach Reitano on the Weight Loss Revolution
On this episode, Dan Nathan sits down with Zachariah Reitano, co-founder and CEO of Ro, to discuss the Ro origin story (2:00), weight-loss medications like Ozempic or Wegovy (11:00), Dan’s Ro Body experience (25:00), drug shortages (35:00), oral alternatives (45:00) and how these ... Show More
54m 34s